PLK1 Inhibition Boosts Gemcitabine Apoptosis in Pancreatic Cancer
In a groundbreaking new study that could reshape therapeutic approaches for pancreatic cancer, researchers have revealed a compelling synergy between PLK1 inhibition and the chemotherapeutic...